Exact Mass: 615.0893

Exact Mass Matches: 615.0893

Found 16 metabolites which its exact mass value is equals to given mass value 615.0893, within given mass tolerance error 0.05 dalton. Try search metabolite list with more accurate mass tolerance error 0.01 dalton.

Trametinib

Trametinib (GSK1120212)

C26H23FIN5O4 (615.0779)


L - Antineoplastic and immunomodulating agents > L01 - Antineoplastic agents > L01E - Protein kinase inhibitors > L01EE - Mitogen-activated protein kinase (mek) inhibitors C274 - Antineoplastic Agent > C163758 - Targeted Therapy Agent > C69145 - Mitogen-Activated Protein Kinase Kinase Inhibitor C274 - Antineoplastic Agent > C2189 - Signal Transduction Inhibitor > C129824 - Antineoplastic Protein Inhibitor C471 - Enzyme Inhibitor > C129825 - Antineoplastic Enzyme Inhibitor D004791 - Enzyme Inhibitors > D047428 - Protein Kinase Inhibitors C471 - Enzyme Inhibitor > C1404 - Protein Kinase Inhibitor D000970 - Antineoplastic Agents Trametinib (GSK1120212; JTP-74057) is an orally active MEK inhibitor that inhibits MEK1 and MEK2 with IC50s of about 2 nM. Trametinib activates autophagy and induces apoptosis[1][2].

   
   

Fmoc-tyr(2-br-z)-oh

Fmoc-tyr(2-br-z)-oh

C32H26BrNO7 (615.0893)


   
   

N-(3-(3-cyclopropyl-1-(2-fluoro-4-iodophenyl)-6,8-diMethyl-2,4,7-trioxo-1,2,3,4,7,8-hexahydropyrido[2,3-d]pyriMidin-5-ylaMino)phenyl)acetaMide

N-(3-(3-cyclopropyl-1-(2-fluoro-4-iodophenyl)-6,8-diMethyl-2,4,7-trioxo-1,2,3,4,7,8-hexahydropyrido[2,3-d]pyriMidin-5-ylaMino)phenyl)acetaMide

C26H23FIN5O4 (615.0779)


   

Dabrafenib Mesylate

Dabrafenib Mesylate

C24H24F3N5O5S3 (615.0892)


C274 - Antineoplastic Agent > C2189 - Signal Transduction Inhibitor > C129824 - Antineoplastic Protein Inhibitor C471 - Enzyme Inhibitor > C1404 - Protein Kinase Inhibitor > C61074 - Serine/Threonine Kinase Inhibitor C274 - Antineoplastic Agent > C163758 - Targeted Therapy Agent > C2336 - Raf Kinase Inhibitor C471 - Enzyme Inhibitor > C129825 - Antineoplastic Enzyme Inhibitor Dabrafenib Mesylate is a potent and selective Raf kinase inhibitor with IC50s of 0.6 and 5.0 nM for RafV600E and c-Raf, respectively.

   

4-Chloro-N-{[1-(4-chlorobenzoyl)-5-methoxy-2-methyl-1H-indol-3-yl]acetyl}-N-(4-methoxyphenyl)benzohydrazide

4-Chloro-N-{[1-(4-chlorobenzoyl)-5-methoxy-2-methyl-1H-indol-3-yl]acetyl}-N-(4-methoxyphenyl)benzohydrazide

C33H27Cl2N3O5 (615.1328)


   

GDP-4-oxo,6-deoxy-D-lyxo-heptose

GDP-4-oxo,6-deoxy-D-lyxo-heptose

C17H23N5O16P2-2 (615.0615)


   

GDP-6-deoxy-4-keto-L-xylo-heptose

GDP-6-deoxy-4-keto-L-xylo-heptose

C17H23N5O16P2-2 (615.0615)


   

GDP-6-deoxy-4-keto-L-ribo-heptose

GDP-6-deoxy-4-keto-L-ribo-heptose

C17H23N5O16P2-2 (615.0615)


   

GDP-6-deoxy-4-keto-D-arabino-heptose

GDP-6-deoxy-4-keto-D-arabino-heptose

C17H23N5O16P2-2 (615.0615)


   

[4-[6-Benzyl-5-[[4-oxo-3-[(4-sulfooxyphenyl)methyl]dioxetan-3-yl]amino]pyrazin-2-yl]phenyl] hydrogen sulfate

[4-[6-Benzyl-5-[[4-oxo-3-[(4-sulfooxyphenyl)methyl]dioxetan-3-yl]amino]pyrazin-2-yl]phenyl] hydrogen sulfate

C26H21N3O11S2 (615.0617)


   

Lamellarin alpha 20-sulfate

Lamellarin alpha 20-sulfate

C29H22NNaO11S (615.0811)


An organic sodium salt of lamellarin alpha 20-hydrogen sulfate. It is isolated from an unidentified ascidian (IIC-197) and exhibits inhibitory activity against HIV-1 integrase.

   

1,N-bis(2,4-dinitrophenyl)-L-histidyl-L-glutamine

1,N-bis(2,4-dinitrophenyl)-L-histidyl-L-glutamine

C23H21N9O12 (615.131)


   

[(2R,3S,4R)-2-[[[[(2R,3S,4R,5R)-5-(6-aminopurin-9-yl)-3,4-dihydroxyoxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-hydroxyphosphoryl]oxymethyl]-4,5-dihydroxyoxolan-3-yl] propanoate

[(2R,3S,4R)-2-[[[[(2R,3S,4R,5R)-5-(6-aminopurin-9-yl)-3,4-dihydroxyoxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-hydroxyphosphoryl]oxymethyl]-4,5-dihydroxyoxolan-3-yl] propanoate

C18H27N5O15P2 (615.0979)


   

(7s,8s,12r,13s)-22-chloro-1,3,8,28-tetrahydroxy-7,12,21-trimethoxy-6-methyl-14,16,19-trioxa-6-azaheptacyclo[15.11.1.0²,¹¹.0⁴,⁹.0¹³,²⁹.0¹⁸,²⁷.0²⁰,²⁵]nonacosa-2,4(9),10,17(29),18(27),20,22,24-octaene-5,26-dione

(7s,8s,12r,13s)-22-chloro-1,3,8,28-tetrahydroxy-7,12,21-trimethoxy-6-methyl-14,16,19-trioxa-6-azaheptacyclo[15.11.1.0²,¹¹.0⁴,⁹.0¹³,²⁹.0¹⁸,²⁷.0²⁰,²⁵]nonacosa-2,4(9),10,17(29),18(27),20,22,24-octaene-5,26-dione

C29H26ClNO12 (615.1143)